SKIN CANCER DRUGS MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2025-2032)

Skin Cancer Drugs Market, By Drug Type (Chemotherapy Drugs, Targeted Therapy Drugs, Immunotherapy Drugs, Hormone Therapy Drugs and Others (Photodynamic Therapy, Cryotherapy and Others)), By Cancer Type (Basal cell carcinoma, Squamous cell carcinoma, Melanoma and Others (Kaposi\\\\\\\'s sarcoma, Mycosis fungoides and Others)), By Route of Administration (Topical, Oral, Injectable and Others (Surgical procedures, radiation therapy and Others)), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By Geography (North America, Latin America, Europe, Middle East & Africa, and Asia Pacific)

Published In: 27 Mar, 2025
Code: CMI6345
Pages: 150
Formats: Excel and PDF
Industry: Pharmaceutical
- Historical Range: 2020 - 2024
- Forecast Period: 2025 - 2032

N/A

Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
Market Purview
- Report Description
  - Market Definition and Scope
- Executive Summary
  - Market Snippet, By Drug Type
  - Market Snippet, By Cancer Type
  - Market Snippet, By Route of Administration
  - Market Snippet, By Distribution Channel
  - Market Snippet, By Region
- Coherent Opportunity Map (COM)
Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
  - Increasing incidence of skin cancers
  - High costs of targeted therapies
  - Combination therapies
- Key Highlights
- Regulatory Scenario
- Recent Trends
- Product Launches/Approvals
- PEST Analysis
- PORTER’s Analysis
- Mergers, Acquisitions, and Collaborations
Global Skin Cancer Drugs Market – Impact of Coronavirus (COVID-19) Pandemic
- COVID-19 Epidemiology
- Supply Side and Demand Side Analysis
- Economic Impact
Global Skin Cancer Drugs Market, By Drug Type, 2020-2032, (US$ Bn)
- Introduction
  - Market Share Analysis, 2025 and 2032 (%)
  - Y-o-Y Growth Analysis, 2021 – 2032
  - Segment Trends
- Chemotherapy Drugs
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Targeted Therapy Drugs
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Immunotherapy Drugs
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Hormone Therapy Drugs
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Others (Photodynamic Therapy, Cryotherapy and Others)
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Global Skin Cancer Drugs Market, By Cancer Type, 2020-2032, (US$ Bn)
- Introduction
  - Market Share Analysis, 2025 and 2032 (%)
  - Y-o-Y Growth Analysis, 2021 – 2032
  - Segment Trends
- Basal cell carcinoma
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Squamous cell carcinoma
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Melanoma
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Others (Kaposi's sarcoma, Mycosis fungoides and Others)
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Global Skin Cancer Drugs Market, By Route of Administration, 2020-2032, (US$ Bn)
- Introduction
  - Market Share Analysis, 2025 and 2032 (%)
  - Y-o-Y Growth Analysis, 2021 – 2032
  - Segment Trends
- Topical
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Oral
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Injectable
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Others (Surgical procedures, radiation therapy and Others)
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Global Skin Cancer Drugs Market, By Distribution Channel, 2020-2032, (US$ Bn)
- Introduction
  - Market Share Analysis, 2025 and 2032 (%)
  - Y-o-Y Growth Analysis, 2021 – 2032
  - Segment Trends
- Hospital Pharmacies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Retail Pharmacies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Online Pharmacies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Global Skin Cancer Drugs Market, By Region, 2020-2032, (US$ Bn)
- Introduction
  - Market Share Analysis, By Sub-region, 2025 and 2032 (%)
  - Y-o-Y Growth Analysis, For Sub-region, 2021 –2032
  - Country Trends
- North America
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2020-2032,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2020-2032,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
    - U.S.
    - Canada
- Latin America
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2020-2032,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2020-2032,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
    - Brazil
    - Argentina
    - Mexico
    - Rest of Latin America
- Europe
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2020-2032,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2020-2032,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
    - Germany
    - U.K.
    - Spain
    - France
    - Italy
    - Russia
    - Rest of Europe
- Asia Pacific
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2020-2032,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2020-2032,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
    - China
    - India
    - Japan
    - Australia
    - South Korea
    - ASEAN
    - Rest of Asia Pacific
- Middle East
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2020-2032,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2020-2032,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country/Sub-region, 2020-2032,(US$ Bn)
    - GCC
    - Israel
    - Rest of Middle East
- Africa
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2020-2032,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2020-2032,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country/Sub-region, 2020-2032,(US$ Bn)
    - South Africa
    - North Africa
    - Central Africa
Competitive Landscape
- Company Profile
  - Novartis
    - Company Highlights
    - Product Portfolio
    - Key Developments
    - Financial Performance
    - Strategies
  - Merck
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Strategies
  - Roche
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Strategies
  - Amgen
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Strategies
  - Pfizer
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Strategies
  - Sun Pharma
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Strategies
  - Bristol-Myers Squibb
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Strategies
  - AstraZeneca
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Strategies
  - Johnson & Johnson
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Strategies
  - Valeant
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Strategies
  - Daiichi Sankyo
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Strategies
  - Takeda Pharmaceutical
    - Company Limited
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Strategies
  - LEO Pharma
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Strategies
  - Mylan N.V.
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Strategies
  - Sanofi
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Strategies
  - Regeneron
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Strategies
  - Eli Lilly
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Strategies
  - Bayer
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Strategies
  - Gilead Sciences
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Strategies
  - Astellas Pharma
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Strategies
- Analyst Views
Section
- References
- Research Methodology
- About us

*Browse 25 market data tables and 29 figures on “Global Skin Cancer Drugs

Market” - Global forecast to 2032

Limited Time Offer - Buy Now

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now